112 related articles for article (PubMed ID: 23789)
1. [Effect of a new beta-adrenoceptor blocking agent, carteolol (OPC-1085). Improvement of the coronary collateral circulation in dogs with chronic coronary artery occlusion (author's transl)].
Ishihara T; Watanabe K; Takenaka F
Arzneimittelforschung; 1977; 27(11):2055-9. PubMed ID: 23789
[No Abstract] [Full Text] [Related]
2. [Transmural coronary blood flow redistribution in the non-ischemic and ischemic canine myocardium with S 2395, a beta-adrenoceptor blocking agent (author's transl)].
Berdeaux PA; Giudicelli JF
Arch Farmacol Toxicol; 1980 Dec; 6(3):209-24. PubMed ID: 6118102
[No Abstract] [Full Text] [Related]
3. [Studies on the action of talinolol (Cordanum, 02-115) on the coronary blood circulation].
Modersohn D; Femmer K
Pharmazie; 1975 Oct; 30(10):652-5. PubMed ID: 689
[No Abstract] [Full Text] [Related]
4. [Effects of Kö 1366 and propranolol on hemodynamics and regional myocardial blood flow in the selective coronary hypotensive dogs (author's transl)].
Tomoike H
Fukuoka Igaku Zasshi; 1975 Apr; 66(4):301-19. PubMed ID: 237808
[No Abstract] [Full Text] [Related]
5. [Effect of a new beta blockader (SD/1601) on positive levelling of the ST epicardial tracing during coronary occlusion in the narcotized dog].
Merlo L; Brusoni B; Minoia G; Marchetti G
Boll Soc Ital Biol Sper; 1977 Mar; 53(6):440-4. PubMed ID: 20906
[No Abstract] [Full Text] [Related]
6. Distinct cardioselectivity of TR2732, a new beta adrenergic blocking agent.
Reyes G; Ramírez T; Hong E
Proc West Pharmacol Soc; 1991; 34():141-4. PubMed ID: 1686323
[No Abstract] [Full Text] [Related]
7. Nipradilol, a beta-adrenoceptor antagonist having a vasodilatory action, attenuates myocardial acidosis induced by coronary artery occlusion in dogs.
Hino T; Hayase N; Chiba K; Ichihara K; Abiko Y
Methods Find Exp Clin Pharmacol; 1989 Jun; 11(6):373-8. PubMed ID: 2568518
[TBL] [Abstract][Full Text] [Related]
8. Hypotensive action of OPC-1427, a new beta-adrenergic blocking agent in rats.
Sugawara K; Takami N; Ozaki M
Arch Int Pharmacodyn Ther; 1979 Aug; 240(2):294-304. PubMed ID: 41497
[TBL] [Abstract][Full Text] [Related]
9. [Pharmacological studies on the combination of a coronary dilator with a beta-receptor blocking agent].
Kadatz R; Diederen W
Arzneimittelforschung; 1972 Sep; 22(9):1449-54. PubMed ID: 4405011
[No Abstract] [Full Text] [Related]
10. Atenolol, regional myocardial blood flow and S-T segment in canine ischaemic myocardium [proceedingins].
Berdeaux A; Boissier JR; Giudicelli JF
Br J Pharmacol; 1976 Nov; 58(3):411P. PubMed ID: 11019
[No Abstract] [Full Text] [Related]
11. On the clinical pharmacology of talinolol, a new beta 1-adrenoceptor blocking agent.
Haustein KO; Fiehring H; Oltmanns G; Femmer K
Int J Clin Pharmacol Biopharm; 1979 Dec; 17(12):465-70. PubMed ID: 43294
[No Abstract] [Full Text] [Related]
12. [Hemodynamic studies at rest and under stress in patients with coronary heart disease after administration of carteolol].
Saborowski F; Dundalek E; Griebenow R; Sy M
Arzneimittelforschung; 1983; 33(2a):310-2. PubMed ID: 6682322
[TBL] [Abstract][Full Text] [Related]
13. Direct and beta-adrenoreceptor blocking effects of 4-(2-hydroxy-3-isopropylaminopropoxy)-indole (LB-46) on myocardial hemodynamics.
Laddu AR; Somani P
Arch Int Pharmacodyn Ther; 1972 Mar; 196(1):5-15. PubMed ID: 4400602
[No Abstract] [Full Text] [Related]
14. Coronary and myocardial effects of dopamine in the conscious dog: parasympatholytic augmentation of pressor and inotropic actions.
Vatner SF; Millard RW; Higgins CB
J Pharmacol Exp Ther; 1973 Nov; 187(2):280-95. PubMed ID: 4147854
[No Abstract] [Full Text] [Related]
15. A further study on antihypertensive action of beta-adrenoceptor blocking agents in conscious, renal hypertensive dogs.
Himori N; Ishimori T; Taira N
Arch Int Pharmacodyn Ther; 1979 Nov; 242(1):115-27. PubMed ID: 44454
[TBL] [Abstract][Full Text] [Related]
16. Cardiovascular responses to phenylephrine and sodium nitroprusside during acute coronary occlusion in dogs.
Hussain ME; Fahim M
Indian J Physiol Pharmacol; 1994 Oct; 38(4):252-8. PubMed ID: 7883288
[TBL] [Abstract][Full Text] [Related]
17. [On the cardiovascular and beta-adrenergic blocking effects produced in the beagle dog by repeated oral administration of talinolol (Cordanum) and propranolol (author's transl)].
Heer S; Femmer K
Pharmazie; 1980; 34(5-6):317-20. PubMed ID: 6106208
[No Abstract] [Full Text] [Related]
18. Circulatory effects of oxprenolol, a new beta-adrenergic blocking agent.
Reale A; Motolese M; Imhof P
Int Z Klin Pharmakol Ther Toxikol; 1970 Jul; 3(3):288-93. PubMed ID: 4394124
[No Abstract] [Full Text] [Related]
19. Beta adrenergic blockade on intramyocardial distribution of coronary blood flow.
Gross GJ; Winbury MM
J Pharmacol Exp Ther; 1973 Dec; 187(3):451-64. PubMed ID: 4149128
[No Abstract] [Full Text] [Related]
20. Beta-blocking and hemodynamic effects of ASL-8052.
Gorczynski RJ; Murthy VS; Hwang TF
J Cardiovasc Pharmacol; 1984; 6(6):1548-59. PubMed ID: 6084788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
